Clinical Trial Update: Epidemiology and Management of Metastatic Breast Cancer

View source ↗

Summary

Clinical trial update sponsored by AstraZeneca discusses epidemiology and management of metastatic breast cancer; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer Nos Metastatic Recurrent | Status: COMPLETED